Skip to main content
. 2017 Jun 19;595(15):5227–5244. doi: 10.1113/JP274068

Table 3.

Arterial blood variables at baseline and near exercise termination for control constant load exercise trial

Baseline Termination Change from baseline
M W M W M W
[K+] (mmol l−1) 4.0 ± 0.2 3.8 ± 0.1 5.5 ± 0.1 5.4 ± 0.1 1.4 ± 0.3 1.6 ± 0.1
[Ca2+] (mmol l−1) 1.19 ± 0.01 1.17±.01 1.25 ± 0.02 1.26 ± 0.01 0.05 ± 0.03 0.09 ± 0.02
[Na+] (mmol l−1) 142 ± 0.1 142 ± 5 145 ± 0.9 146 ± 0.9 3.1 ± 0.9 3.8 ± 0.8
[Cl] (mmol l−1) 108 ± 1 110 ± 1 112 ± 0.9 112 ± 0.9 3.6 ± 1.0 2.3 ± 0.5
[Hb] (g dl−1) 14.5 ± 0.3 12.9 ± 0.2* 15.6 ± 0.3 14.1 ± 0.2, * 1.2 ± 0.3 1.1 ± 0.2
Hct (%) 44 ± 1 40 ± 1* 48 ± 1 43 ± 1, * 3.5 ± 0.8 3.4 ± 0.5
FHHb (%) 1.3 ± 0.2 1.5 ± 0.2 4.4 ± 0.6 4.2 ± 0.6 3.1 ± 0.7 2.7 ± 0.7
[HCO3 ] (mmol l−1) 22.4 ± 0.3 20.3 ± 0.5* 12.1 ± 0.9 10.6 ± 0.9, * −10.2 ± 1.0 −9.6 ± 1.4
Base excess (mmol l−1) −1.4 ± 0.4 −3.2 ± 0.3* −14.6 ± 1.2 −16.9 ± 1.3 −13.2 ± 1.2 −13.7 ± 1.2
PaO2 (mmHg) 99 ± 4 100 ± 1 94 ± 3 96 ± 2 −5 ± 5 −3 ± 3
(range) (89–117) (93–104) (81–111) (86–106) (−23–21) (−17–8)
P aC O2 (mmHg) 37 ± 1 34 ± 2 31 ± 1 31 ± 1 − ± 2 −3 ± 1
(range) (29–41) (26–38) (24–34) (28–33) (−17–0) (−6–2)
PAO2 (mmHg) 110 ± 3 110 ± 2 117 ± 3 117 ± 1 7 ± 3 7 ± 1
(range) (100–124) (106–120) (113–123) (113–120) (−5–22) (0–10)
A‐aDO2 (mmHg) 11 ± 1 9 ± 2 23 ± 3 21 ± 3 12 ± 3 11 ± 3
(range) (5–15) (7–17) (12–33) (8–34) (1–23) (−1–25)
CaO2 (ml dl−1) 20.1 ± 0.5 18.1 ± 0.2* 21.0 ± 0.3 18.9 ± 0.4, * 0.9 ± 0.4 0.7 ± 0.2
1 CaO2 (ml dl−1) 20.1 ± 0.5 18.1 ± 0.2* 21.7 ± 0.4 19.6 ± 0.4, * 1.6 ± 0.4 1.4 ± 0.2

Values are means ± SEM. M, men; W, women; A‐aDO2, alveolar‐to‐arterial oxygen gradient; CaO2, arterial oxygen content; 1 CaO2, ideal CaO2 if no desaturation was present; FHHb, fraction of deoxyhaemoglobin; Hb, haemoglobin; Hct, haematocrit; P aC O2, arterial oxygen tension; PAO2, alveolar oxygen tension. *Significantly different from men; †significantly different from baseline; P < 0.05.